MedPath

Comparing QLB Type I Block to Intraperitoneal Instillation Added to Wound Infiltration for Postoperative Cesarian Pain

Not Applicable
Recruiting
Conditions
Analgesia
Registration Number
NCT06129032
Lead Sponsor
Ataturk University
Brief Summary

This study aimed to compare the efficacy of local anaesthetic infiltration into all layers of the anterior abdominal wall with peritoneal instillation and QLB type I for pain reduction in women undergoing elective cesarean section under spinal anaesthesia.

Detailed Description

This study will be conducted as a prospective randomized, controlled, double-blind trial following the approval of the ethical committee at Atatürk University Medical Faculty Hospital and after obtaining written consent from the participating patients. The study will include pregnant women aged 18 to 50 with American Society of Anesthesiologists (ASA) II classification, full-term and singleton pregnancies planned to undergo cesarean section using Pfannenstiel incision with spinal anaesthesia. Using a randomisation procedure, the participants will be allocated into two equal groups: Group IPLA+ LWI and Group QLB.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • aged between 18 to 50
  • American Society of Anesthesiologists (ASA) II classification,
  • full-term and singleton pregnancies planned to undergo cesarean section
  • using Pfannenstiel incision
  • spinal anaesthesia
Exclusion Criteria
  • whom neuraxial anaesthesia is contraindicated,
  • those who are allergic to drugs to be used in the study,
  • who refused to participate in the study,
  • those with BMI>35 kg/m2,
  • ASA score ≥3 or higher,
  • diabetes mellitus, preeclampsia, cardiovascular disease, chronic pain and neuropathic pain,
  • individuals who have received opioids during the surgical procedure for intraoperative pain,
  • patients who have undergone abdominal surgery,
  • patients who have experienced a transition from spinal anaesthesia to general anaesthesia due to failure,
  • those with excessive bleeding during the operation,
  • who have uterine atony,
  • those who have a drain placed in the area to be infiltrated,
  • those who cannot understand the Visual Analog Scale (VAS),
  • who have a history of drug addiction and psychiatric disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
difference between total opioid consumption in 24 hourspostoperative 24 hours

The study will involve monitoring the intake of opioids at specific time intervals (2nd, 4th, 6th, 12th, and 24th hours), calculating the cumulative opioid consumption until the 24th hour

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Atatürk University

🇹🇷

Erzurum, Turkey

Atatürk University
🇹🇷Erzurum, Turkey
Ayşenur Dostbil
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.